Investing-News.Com
Information for Investors

GENELABS TECH INC, (GNLB) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

GENELABS TECH INC, (GNLB) Stock Rating Learn More

Our Overall Rating on GENELABS TECH INC,  GNLB is Not Available
Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of novel pharmaceutical products for human health. It is developing, Prestara, an investigational drug for women with systemic lupus erythematosus. The company is also pursuing the discovery of antiviral compounds for treatment of hepatitis C virus infections and is initiating preclinical development work. The company has collaborations with Watson Pharmaceuticals, Inc. and Tanabe Seiyaku Co., Ltd. Genelabs Technologies was incorporated in 1985 and is based in Redwood City, California.
Our Not Available Rating on GNLB was issued on 12/02/2008

GENELABS TECH INC Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces GENELABS TECH INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in GENELABS TECH INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on GENELABS TECH INC. This software is specially designed to give precision entry and exit points on GENELABS TECH INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When GENELABS TECH INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even GENELABS TECH INC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: stock investing program  fidelity independent advisor  stock market option research  short term stock trading  penny stock investing 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Navigating the Micro-Cap Biotech Minefield (at Seeking Alpha)

GENELABS TECHNOLOGIES INC /CA Financials (EDGAR Online Financials)

New Star Analyst Rankings for Genelabs Technologies, Inc. (StarMine)

GENELABS TECHNOLOGIES INC /CA Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)

Genelabs Reports Results for the Third Quarter and First Nine Months of 2008 (Business Wire)

GENELABS TECHNOLOGIES INC /CA Files SEC form 10-Q, Quarterly Report (EDGAR Online)

GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc. (PR Newswire)

GENELABS TECHNOLOGIES INC /CA Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)

GlaxoSmithKline to Acquire Genelabs Technologies For $57M (at Seeking Alpha)

Glaxo Saves Genelabs (at Forbes.com)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.